Previous 10 | Next 10 |
Pressure BioSciences, Inc. (PBIO) Q3 2020 Results Conference Call November 17, 2020 04:30 PM ET Company Participants Rick Schumacher - CEO Jeff Peterson - Chairman Conference Call Participants Gary Zwetchkenbaum - Plum Tree Consulting Presentation Operator Greetings, and welcome to Pressure B...
Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update Instrument Sales Increase 68%, Total Revenue Increases 7%, Operating Loss Decreases 23% (Q/Q); Planned Release of Revolutionary UST System in Mid-2021 Expected to Drive Major Rev...
Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update Conference Call Scheduled for Tuesday, November 17th at 4:30pm ET PR Newswire SOUTH EASTON, Mass., Nov. 16, 2020 SOUTH EASTON, Mass. , Nov. 16, 2020 /PR...
Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform Patented UST Platform, with Unique Ability to Prepare High Quality Commercial Scale Nanoemulsions, Expected to Significantly Impact PBI's Growth and Profitability in 2021 PR News...
Pressure BioSciences Achieves Critical Milestone in Revolutionary Nanoemulsification Technology Development; Enters Production Era for Commercial System Development Company Locks-in Final Design Specifications, Begins Initial Build of Proprietary Ultra Shear Technology System, &...
Pressure BioSciences (OTCQB: PBIO) recently announced its receipt of a pivotal U.S. patent for “Sample Preparation Devices and Methods,” which expands its already significant intellectual property (“IP”) portfolio. This award increases Pressure BioSciences’...
Pressure BioSciences develops and sells pressure-based instruments and consumables to the global life sciences, food and beverage, and other large research markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled "Sample Preparation Device...
SOUTH EASTON, Mass. , Aug. 12, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide Life Sciences and other in...
Pressure BioSciences (OTCQB: PBIO) on Tuesday announced that it will host a teleconference to discuss its first quarter 2020 financial results and to provide a business update, including the Company’s progress made in the development of its Ultra Shear Technology(TM) ("UST(TM)) Platfo...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...